Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation, 128 16
S. Salpeter, T. Ormiston, E. Salpeter (2002)
Cardioselective beta-blockers for reversible airway disease.The Cochrane database of systematic reviews, 4
S. Chatterjee, D. Chaudhuri, R. Vedanthan, V. Fuster, B. Ibáñez, S. Bangalore, D. Mukherjee (2013)
Early intravenous beta-blockers in patients with acute coronary syndrome--a meta-analysis of randomized trials.International journal of cardiology, 168 2
M. Stearne, S. Palmer, M. Hammersley, S. Franklin, R. Spivey, J. Levy, C. Tidy, N. Bell, J. Steemson, B. Barrow, R. Coster, K. Waring, J. Nolan, E. Truscott, N. Walravens, L. Cook, H. Lampard, C. Merle, P. Parker, J. Mcvittie, I. Draisey, L. Murchison, A. Brunt, M. Williams, D. Pearson, X. Petrie, M. Lean, D. Walmsley, M. Lyall, E. Christie, J. Church, E. Thomson, A. Farrow, J. Stowers, M. Stowers, K. McHardy, N. Patterson, A. Wright, N. Levi, A. Shearer, R. Thompson, G. Taylor, S. Rayton, M. Bradbury, A. Glover, A. Smyth-Osbourne, C. Parkes, J. Graham, P. England, S. Gyde, C. Eagle, B. Chakrabarti, J. Smith, J. Sherwell, E. Kohner, A. Dornhurst, M. Doddridge, M. Dumskyj, S. Walji, P. Sharp, M. Sleightholm, G. Vanterpool, C. Rose, G. Frost, M. Roseblade, S. Elliott, S. Forrester, M. Foster, K. Myers, R. Chapman, J. Hayes, R. Henry, M. Featherston, G. Archbold, M. Copeland, R. Harper, I. Richardson, S. Martín, H. Davison, D. Hadden, L. Kennedy, A. Atkinson, A. Culbert, C. Hegan, H. Tennet, N. Webb, I. Robinson, J. Holmes, P. Bell, D. McCance, J. Rutherford, S. Nesbitt, A. Spathis, S. Hyer, M. Nanson, L. James, J. Tyrell, C. Davis, P. Strugnell, M. Booth, H. Petrie, D. Clark, B. Rice, S. Hulland, J. Barron, J. Yudkin, B. Gould, J. Singer, A. Badenock, M. Eckert, K. Alibhai, E. Marriot, C. Cox, R. Price, M. Fernandez, A. Ryle, S. Clarke, G. Wallace, E. Mehmed, S. Macfarlane, R. Greenwood, J. Wilson, M. Denholm, R. Temple, K. Whitfield, F. Johnson, C. Munroe, S. Gorick, E. Duckworth, M. Flatman, S. Rainbow, L. Borthwick, D. Wheatcroft, R. Seaman, R. Christie, W. Wheatcroft, P. Musk, J. White, S. McDougal, M. Bond, P. Raniga, R. Newton, R. Jung, C. Roxburgh, B. Kilgallon, L. Dick, N. Waugh, S. Kilby, A. Ellingford, J. Burns, C. Fox, M. Holloway, H. Coghill, N. Hein, A. Fox, W. Cowan, M. Richard, K. Quested, S. Evans, R. Paisey, N. Brown, A. Tucker, R. Paisey, F. Garrett, J. Hogg, P. Park, K. Williams, Philip Harvey, R. Wilcocks, S. Mason, J. Frost, C. Warren, P. Rocket, L. Bower, J. Roland, D. Brown, J. Youens, K. Stanton-King, H. Mungall, W. Maddison, D. Donnelly, S. King, P. Griffin, S. Smith, S. Church, G. Dunn, Apr Wilson, K. Palmer, P. Brown, D. Humphriss, A. Davidson, R. Rose, L. Armistead, S. Townsend, P. Poon, I. Peacock, N. Culverwell, M. Charlton, B. Connolly, J. Peacock, J. Barrett, J. Wain, W. Beeston, G. King, P. Hill, A. Boulton, A. Robertson, Katoulis, A. Olukoga, H. McDonald, S. Kumar, F. Abouaesha, B. Abuaisha, E. Knowles, S. Higgins, J. Booker, J. Sunter, K. Breislin, R. Parker, P. Raval, J. Curwell, H. Davenport, G. Shawcross, A. Prest, J. Grey, H. Cole, C. Sereviratne, R. Young, T. Dornan, J. Clyne, M. Gibson, I. O'Connell, L. Wong, S. Wilson, K. Wright, C. Wallace, D. McDowell, A. Burden, E. Sellén, R. Gregory, M. Roshan, N. Vaghela, M. Burden, C. Sherriff, J. Clarke, J. Grenfell, J. Tooke, K. Macleod, C. Searnark, M. Rammell, C. Pym, J. Stockman, C. Yeo, J. Piper, L. Leighton, E. Green, M. Hoyle, K. Jones, A. Hudson, A. James, A. Shore, A. Higham, B. Martin (1998)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 317
(Piccini JP, Allen LA. Heart failure complicated by atrial fibrillation. Don’t bury the beta-blockers just yet. JACC Heart Fail. 2017.)
Piccini JP, Allen LA. Heart failure complicated by atrial fibrillation. Don’t bury the beta-blockers just yet. JACC Heart Fail. 2017.Piccini JP, Allen LA. Heart failure complicated by atrial fibrillation. Don’t bury the beta-blockers just yet. JACC Heart Fail. 2017., Piccini JP, Allen LA. Heart failure complicated by atrial fibrillation. Don’t bury the beta-blockers just yet. JACC Heart Fail. 2017.
P. Lechat, M. Packer, Stephan Chalon, M. Cucherat, Tarek Arab, J. Boissel (1998)
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials.Circulation, 98 12
(2010)
Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)Eur Heart J, 31
Tien-Yu Lin, Chung-Yu Chen, Yaw-Bin Huang (2017)
Evaluating the effectiveness of different beta-adrenoceptor blockers in heart failure patients.International journal of cardiology, 230
V. Su, Yu-Sheng Chang, Yu-Wen Hu, M. Hung, Shuo-Ming Ou, F. Lee, K. Chou, Kuang-Yao Yang, D. Perng, Tzeng-Ji Chen, Chia-Jen Liu (2016)
Carvedilol, Bisoprolol, and Metoprolol Use in Patients With Coexistent Heart Failure and Chronic Obstructive Pulmonary DiseaseMedicine, 95
D. Kotecha, J. Holmes, H. Krum, D. Altman, L. Manzano, J. Cleland, G. Lip, A. Coats, B. Andersson, P. Kirchhof, T. Lueder, H. Wedel, G. Rosano, M. Shibata, A. Rigby, M. Flather (2014)
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysisThe Lancet, 384
Jingmin Zhou, Haiming Shi, Jian Zhang, Yongxin Lu, M. Fu, J. Ge (2010)
Rationale and design of the β‐blocker in heart failure with normal left ventricular ejection fraction (β‐PRESERVE) studyEuropean Journal of Heart Failure, 12
P. Lechat, J. Hulot, S. Escolano, A. Mallet, A. Leizorovicz, Marie Werhlen-Grandjean, G. Pochmalicki, H. Dargie (2001)
Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II TrialCirculation: Journal of the American Heart Association, 103
D. Lemon (1987)
Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1Journal of Emergency Medicine, 5
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 62 16
S. Yusuf, R. Peto, J. Lewis, R. Collins, P. Sleight (1985)
Beta blockade during and after myocardial infarction: an overview of the randomized trials.Progress in cardiovascular diseases, 27 5
C. January, L. Wann, J. Alpert, H. Calkins, J. Cigarroa, J. Cleveland, J. Conti, P. Ellinor, M. Ezekowitz, M. Field, K. Murray, R. Sacco, W. Stevenson, P. Tchou, C. Tracy, C. Yancy (2014)
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Circulation, 130 23
R. Doughty, S. MacMahon, N. Sharpe (1994)
Beta-blockers in heart failure: promising or proved?Journal of the American College of Cardiology, 23 3
R. Bahn, Henry Burch, David Cooper, J. Garber, M. Greenlee, I. Klein, Peter Laurberg, I. McDougall, Victor Montori, S. Rivkees, Douglas Ross, Julie Sosa, Marius Stan (2011)
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.Thyroid : official journal of the American Thyroid Association, 21 6
N. Shiba, Tomohiro Tada, T. Shinozaki, K. Fukuda, J. Takahashi, J. Watanabe (2005)
Beta-blocker is Effective in Reducing Cardiovascular Events in Patients with Chronic Heart Failure Complicated by Atrial FibrillationJournal of Cardiac Failure, 11
T. Tagami, Y. Yambe, Tsuyoshi Tanaka, Takashi Tanaka, A. Ogo, H. Yoshizumi, Kazuo Kaise, K. Higashi, M. Tanabe, Satoko Shimazu, T. Usui, A. Shimatsu, M. Naruse (2012)
Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease.Internal medicine, 51 17
Å. Hjalmarson, J. Herlitz, S. Holmberg, L. Rydén, K. Swedberg, A. Vedin, F. Waagstein, A. Waldenström, J. Waldenström, H. Wedel, L. Wilhelmsen, C. Wilhelmsson (1983)
The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction.Circulation, 67 6 Pt 2
P. Deedwania, T. Giles, M. Klibaner, J. Ghali, J. Herlitz, P. Hildebrandt, J. Kjekshus, J. Špinar, J. Vítovec, H. Stanbrook, J. Wikstrand (2005)
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.American heart journal, 149 1
(1982)
A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results.JAMA, 247 12
(University of Birmingham. Rate control therapy evaluation in permanent atrial fibrillation (RATE-AF) [ClinicalTrials.gov identifier NCT02391337]. US National Institutes of Health, ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02391337.)
University of Birmingham. Rate control therapy evaluation in permanent atrial fibrillation (RATE-AF) [ClinicalTrials.gov identifier NCT02391337]. US National Institutes of Health, ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02391337.University of Birmingham. Rate control therapy evaluation in permanent atrial fibrillation (RATE-AF) [ClinicalTrials.gov identifier NCT02391337]. US National Institutes of Health, ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02391337., University of Birmingham. Rate control therapy evaluation in permanent atrial fibrillation (RATE-AF) [ClinicalTrials.gov identifier NCT02391337]. US National Institutes of Health, ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02391337.
A. Bui, T. Horwich, G. Fonarow (2011)
Epidemiology and risk profile of heart failureNature Reviews Cardiology, 8
S. Haas, T. Vos, R. Gilbert, H. Krum (2003)
Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.American heart journal, 146 5
(2015)
Treatment of hypertension in patients with coronary artery disease. A scientific statement from the American Heart Association, American College of Cardiology, and American Society of HypertensionHypertension, 65
D. Wijeysundera, D. Duncan, C. Nkonde-Price, S. Virani, J. Washam, K. Fleischmann, L. Fleisher (2014)
Perioperative Beta Blockade in Noncardiac Surgery: A Systematic Review for the 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery A Report of the American College of Cardiology/American Heart Association Task Force on Practice GCirculation, 130
(2013)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med, 187
P. Andell, D. Erlinge, J. Smith, J. Sundström, B. Lindahl, S. James, S. Koul (2015)
β‐Blocker Use and Mortality in COPD Patients After Myocardial Infarction: A Swedish Nationwide Observational StudyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 4
J. Cruickshank (2007)
Are we misunderstanding beta-blockers.International journal of cardiology, 120 1
K. Swedberg, L. Olsson, A. Charlesworth, J. Cleland, P. Hanrath, M. Komajda, M. Metra, C. Torp-Pedersen, P. Poole‐Wilson (2005)
Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.European heart journal, 26 13
E. Crystal, S. Connolly, Khaled Sleik, T. Ginger, S. Yusuf (2002)
Interventions on Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Heart Surgery: A Meta-AnalysisCirculation: Journal of the American Heart Association, 106
(Barsness GW, Holmes DR Jr, editors. Coronary Artery Disease: New Approaches without Traditional Revascularization. London: Springer; 2011.)
Barsness GW, Holmes DR Jr, editors. Coronary Artery Disease: New Approaches without Traditional Revascularization. London: Springer; 2011.Barsness GW, Holmes DR Jr, editors. Coronary Artery Disease: New Approaches without Traditional Revascularization. London: Springer; 2011., Barsness GW, Holmes DR Jr, editors. Coronary Artery Disease: New Approaches without Traditional Revascularization. London: Springer; 2011.
R. Roberts, W. Rogers, H. Mueller, C. Lambrew, D. Diver, Hugh Smith, J. Willerson, G. Knatterud, S. Forman, E. Passamani (1991)
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.Circulation, 83 2
S. Bhatt, J. Wells, G. Kinney, G. Washko, M. Budoff, Young-il Kim, W. Bailey, H. Nath, J. Hokanson, E. Silverman, J. Crapo, M. Dransfield (2015)
β-Blockers are associated with a reduction in COPD exacerbationsThorax, 71
D. Bell, Mary Lukas, F. Holdbrook, M. Fowler (2006)
The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysisCurrent Medical Research and Opinion, 22
S. Coiro, N. Girerd, P. Rossignol, J. Ferreira, A. Maggioni, B. Pitt, I. Tritto, G. Ambrosio, K. Dickstein, F. Zannad (2017)
Association of beta‐blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched‐cohort analysis from the High‐Risk Myocardial Infarction Database InitiativeEuropean Journal of Heart Failure, 19
G. Barsness, D. Holmes (2012)
Coronary artery disease : new approaches without traditional revascularization
M. Tendera, V. Aboyans, M. Bartelink, I. Baumgartner, Denis Clement, Jean-Philippe Collet, A. Cremonesi, M. Carlo, R. Erbel, F. Fowkes, M. Heras, S. Kownator, E. Minar, J. Ostergren, D. Poldermans, V. Riambau, M. Roffi, J. Röther, Horst Sievert, M. Sambeek, T. Zeller (2012)
ESC Guidelines on the Diagnosis and Treatment of Peripheral Artery DiseasesRevista Espanola De Cardiologia, 65
S. Gottlieb, R. McCarter, R. Vogel (1998)
Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction.The New England journal of medicine, 339 8
(Aubert R. Diabetes in America. DIANE Publishing, 2nd edition. NIH Publication No. 95-1468. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995.)
Aubert R. Diabetes in America. DIANE Publishing, 2nd edition. NIH Publication No. 95-1468. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995.Aubert R. Diabetes in America. DIANE Publishing, 2nd edition. NIH Publication No. 95-1468. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995., Aubert R. Diabetes in America. DIANE Publishing, 2nd edition. NIH Publication No. 95-1468. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995.
J. Gore (2015)
Treatment of Hypertension in Patients with Coronary Artery DiseaseNEJM Journal Watch, 2015
Shi-jun Li, U. Sartipy, L. Lund, U. Dahlström, M. Adiels, M. Petzold, M. Fu (2015)
Prognostic Significance of Resting Heart Rate and Use of &bgr;-Blockers in Atrial Fibrillation and Sinus Rhythm in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Swedish Heart Failure RegistryCirculation: Heart Failure, 8
J. Hirst, A. Farmer, B. Feakins, J. Aronson, R. Stevens (2015)
Quantifying the effects of diuretics and β-adrenoceptor blockers on glycaemic control in diabetes mellitus - a systematic review and meta-analysis.British journal of clinical pharmacology, 79 5
P. Short, S. Lipworth, D. Elder, S. Schembri, B. Lipworth (2011)
Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort studyThe BMJ, 342
D. Veldhuisen, A. Cohen-Solal, M. Böhm, S. Anker, D. Babalis, M. Roughton, A. Coats, P. Poole‐Wilson, M. Flather (2009)
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).Journal of the American College of Cardiology, 53 23
R. Vries, A. Heuvel, D. Lok, R. Claessens, P. Bernink, W. Pasteuning, J. Kingma, P. Dunselman (1996)
Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectoris. The Netherlands Working Group on Cardiovascular Research (WCN).International journal of cardiology, 57 2
D. Kao, Gordon Davis, Ryan Aleong, C. O'connor, M. Fiuzat, P. Carson, I. Anand, J. Plehn, S. Gottlieb, M. Silver, J. Lindenfeld, Alan Miller, M. White, G. Murphy, W. Sauer, M. Bristow (2013)
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationEuropean Journal of Heart Failure, 15
R. Vries, Ad Heuvel, Dirk Lok, Rich Claessens, P. Bernink, W. Pasteuning, J. Kingma, P. Dunselman (1996)
Nifedipine gastrointestinal therapeutic system versus atenolol in stable angina pectorisInternational Journal of Cardiology, 57
C. Rosendorff (1993)
Beta-blocking agents with vasodilator activity.Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 11 4
H. Huang, K. Fox (2012)
The impact of beta-blockers on mortality in stable angina: a meta-analysisScottish Medical Journal, 57
J. McMurray, L. Køber, M. Robertson, H. Dargie, W. Colucci, J. López-Sendón, W. Remme, D. Sharpe, I. Ford (2005)
Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.Journal of the American College of Cardiology, 45 4
D. Castagno, P. Jhund, J. McMurray, J. Lewsey, E. Erdmann, F. Zannad, W. Remme, J. López-Sendón, P. Lechat, F. Follath, C. Höglund, V. Mareev, Z. Sadowski, Ricardo Seabra-Gomes, H. Dargie (2010)
Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS‐II) trialEuropean Journal of Heart Failure, 12
J. Cadrin-Tourigny, Azadeh Shohoudi, D. Roy, M. Talajic, R. Tadros, B. Mondésert, K. Dyrda, Léna Rivard, J. Andrade, L. Macle, P. Guerra, B. Thibault, M. Dubuc, P. Khairy (2017)
Decreased Mortality With Beta-Blockers in Patients With Heart Failure and Coexisting Atrial Fibrillation: An AF-CHF Substudy.JACC. Heart failure, 5 2
A. Sakamoto, T. Hamasaki, M. Kitakaze (2014)
Perioperative Landiolol Administration reduces Atrial Fibrillation after Cardiac Surgery: A Meta-analysis of Randomized Controlled TrialsAdvances in Therapy, 31
M. Gheorghiade, W. Colucci, K. Swedberg (2003)
&bgr;-Blockers in Chronic Heart FailureCirculation: Journal of the American Heart Association, 107
Stephan Jacob, K. Rett, E. Henriksen (1998)
Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents?American journal of hypertension, 11 10
(2008)
Handbook of nephrology and hypertension
C. January, L. Wann, Joseph Alpert, H. Calkins, Joaquin Cigarroa, Joseph Cleveland, Jamie Conti, P. Ellinor, M. Ezekowitz, Michael Field, Katherine Murray, Ralph Sacco, William Stevenson, Patrick Tchou, C. Tracy, C. Yancy (2014)
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Circulation, 130 23
G. Montalescot, U. Sechtem, S. Achenbach, F. Andreotti, C. Arden, A. Budaj, R. Bugiardini, F. Crea, T. Cuisset, C. Mario, J. Ferreira, B. Gersh, A. Gitt, J. Hulot, N. Marx, L. Opie, M. Pfisterer, E. Prescott, F. Ruschitzka, M. Sabaté, R. Senior, D. Taggart, E. Wall, C. Vrints, J. Zamorano, H. Baumgartner, Jeroen Bax, H. Bueno, V. Dean, C. Deaton, Ç. Erol, R. Fagard, R. Ferrari, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M. Piepoli, P. Ponikowski, P. Sirnes, J. Tamargo, M. Tendera, A. Torbicki, W. Wijns, S. Windecker, M. Valgimigli, M. Claeys, N. Donner‐Banzhoff, Herbert Frank, C. Funck-Brentano, O. Gaemperli, J. González-Juanatey, M. Hamilos, S. Husted, S. James, K. Kervinen, S. Kristensen, A. Maggioni, A. Pries, F. Romeo, L. Rydén, M. Simoons, P. Steg, A. Timmis, A. Yıldırır (2013)
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.European heart journal, 34 38
K. Malmberg, J. Herlitz, Aå. Hjakmarson, L. Rydén (1989)
Effects of metoprolol on mortality and late infarction in diabetics with suspected acute myocardial infarction. Retrospective data from two large studies.European heart journal, 10 5
T. Gundersen, A. Abrahamsen, J. Kjekshus, Per R0Nnevik (1982)
Timolol‐related Reduction in Mortality and Reinfarction in Patients Ages 65‐75 Years Surviving Acute Myocardial InfarctionCirculation, 66
Hui-shan Wang, Zeng-wei Wang, Z. Yin (2014)
Carvedilol for Prevention of Atrial Fibrillation after Cardiac Surgery: A Meta-AnalysisPLoS ONE, 9
(2012)
Beta-blockers for hypertensionCochrane Database Syst Rev., 11
A. Camm, P. Kirchhof, G. Lip, U. Schotten, I. Savelieva, S. Ernst, I. Gelder, N. Al-Attar, G. Hindricks, B. Prendergast, H. Heidbuchel, O. Alfieri, A. Angelini, D. Atar, P. Colonna, R. Caterina, J. Sutter, A. Goette, B. Gorenek, M. Heldal, Stefan Hohloser, P. Kolh, J. Heuzey, P. Ponikowski, F. Rutten, A. Vahanian, A. Auricchio, Jeroen Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, Richard Hobbs, P. Kearney, T. McDonagh, B. Popescu, Željko Reiner, U. Sechtem, P. Sirnes, M. Tendera, P. Vardas, Petr Widimsky, V. Agladze, E. Aliot, T. Balabanski, C. Blomstrom-Lundqvist, A. Capucci, H. Crijns, B. Dahlöf, T. Folliguet, M. Glikson, M. Goethals, D. Gulba, S. Ho, R. Klautz, S. Kose, John Mcmurray, P. Filardi, P. Raatikainen, M. Salvador, M. Schalij, A. Shpektor, J. Sousa, J. Stȩpińska, H. Uuetoa, J. Zamorano, I. Zupan (2010)
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 12 10
K. Ellison, G. Hafley, K. Hickey, J. Kellen, J. Coromilas, K. Stein, Kerry Lee, A. Buxton (2002)
Effect of (cid:1) -Blocking Therapy on Outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT)
Zhengming Chen, H. Pan, Yiping Chen, R. Peto, R. Collins, Lixin Jiang, J. Xie, Lisheng Liu, Commit (2005)
Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trialThe Lancet, 366
(Held PH, Yusuf S. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J. 1993;14 Suppl F:18–25.)
Held PH, Yusuf S. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J. 1993;14 Suppl F:18–25.Held PH, Yusuf S. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J. 1993;14 Suppl F:18–25., Held PH, Yusuf S. Effects of beta-blockers and calcium channel blockers in acute myocardial infarction. Eur Heart J. 1993;14 Suppl F:18–25.
I. Gussak, Charles Antzelevitch, Arthur Wilde, Paul Friedman, Michael Ackerman, Win Shen (2008)
Electrical diseases of the heart. Genetics, mechanisms, treatment, prevention.
Zacharias Fj (1973)
Beta blockers in hypertension.Bruxelles medical, Spec No 0
R. Pauwels (1996)
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION, 45
P. Held, S. Yusuf (1993)
Effects of beta-blockers and calcium channel blockers in acute myocardial infarction.European heart journal, 14 Suppl F
Jennifer Taylor (2013)
2013 ESH/ESC guidelines for the management of arterial hypertension.European heart journal, 34 28
(2013)
Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis
J. Kostis, M. Sanders (2005)
The association of heart failure with insulin resistance and the development of type 2 diabetes.American journal of hypertension, 18 5 Pt 1
D. Lloyd‐Jones, Robert Adams, Todd Brown, M. Carnethon, S. Dai, Giovanni Simone, T. Ferguson, E. Ford, K. Furie, C. Gillespie, A. Go, K. Greenlund, Nancy Haase, S. Hailpern, P. Ho, V. Howard, B. Kissela, S. Kittner, D. Lackland, L. Lisabeth, A. Marelli, Mary McDermott, J. Meigs, D. Mozaffarian, M. Mussolino, G. Nichol, Véronique Roger, W. Rosamond, R. Sacco, P. Sorlie, R. Stafford, T. Thom, S. Wasserthiel-Smoller, Nathan Wong, J. Wylie-Rosett (2010)
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.Circulation, 121 7
M. Böhm, A. Link, Danlin Cai, M. Nieminen, G. Filippatos, Réda Salem, A. Solal, Bidan Huang, R. Padley, M. Kivikko, A. Mebazaa (2011)
Beneficial association of &bgr;-blocker therapy on recovery from severe acute heart failure treatment: Data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial*Critical Care Medicine, 39
N. Misumida, K. Harjai, S. Kernis, Y. Kanei (2016)
Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-AnalysisJournal of Cardiovascular Pharmacology and Therapeutics, 21
P. Poole‐Wilson, K. Swedberg, J. Cleland, A. Lenarda, P. Hanrath, M. Komajda, J. Lubsen, B. Lutiger, M. Metra, W. Remme, C. Torp-Pedersen, A. Scherhag, A. Skene (2003)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialThe Lancet, 362
S. Badve, M. Roberts, C. Hawley, A. Cass, A. Garg, H. Krum, A. Tonkin, V. Perkovic (2011)
Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis.Journal of the American College of Cardiology, 58 11
D. Veldhuisen, H. Aass, D. Allaf, P. Dunselman, L. Gullestad, M. Halinen, J. Kjekshus, L. Ohlsson, H. Wedel, J. Wikstrand (2006)
Presence and development of atrial fibrillation in chronic heart failureEuropean Journal of Heart Failure, 8
C. Tisher, C. Wilcox (2008)
Comprar Handbook of Nephrology and Hypertension 6e | C. C. Tisher | 9780781795302 | Lippincott Williams & Wilkins
Feng Liu, Yanmei Chen, Xuguang Feng, Zhonghua Teng, Ye Yuan, J. Bin (2014)
Effects of Beta-Blockers on Heart Failure with Preserved Ejection Fraction: A Meta-AnalysisPLoS ONE, 9
CIBIS-II Committees (1999)
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 353
S. Ventrella, I. Klein (1994)
Beta-Adrenergic Receptor Blocking Drugs in the Management of HyperthyroidismEndocrinologist, 4
H. Seguchi, H. Nakamura, N. Aosaki, Y. Homma, Y. Mikami, Shigekazu Takahashi (2005)
Effects of carvedilol on serum lipids in hypertensive and normotensive subjectsEuropean Journal of Clinical Pharmacology, 38
(2001)
Effect of carvedilol on survival in severe chronic heart failureN Engl J Med, 344
(Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2016. http://www.ginasthma.org)
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2016. http://www.ginasthma.orgGlobal Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2016. http://www.ginasthma.org, Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2016. http://www.ginasthma.org
Yoshiaki Kubota, K. Asai, Erito Furuse, Shunichi Nakamura, Koji Murai, Y. Tsukada, W. Shimizu (2015)
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 10
L. Poirier, J. Cléroux, A. Nadeau, Y. Lacourciére (2001)
Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patientsJournal of Hypertension, 19
S. Husted, E. Ohman (2015)
Pharmacological and emerging therapies in the treatment of chronic anginaThe Lancet, 386
J. McMurray, S. Adamopoulos, S. Anker, A. Auricchio, M. Böhm, K. Dickstein, V. Falk, G. Filippatos, C. Fonseca, M. Gómez-Sánchez, T. Jaarsma, L. Køber, G. Lip, A. Maggioni, A. Parkhomenko, B. Pieske, B. Popescu, P. Rønnevik, F. Rutten, J. Schwitter, P. Seferovic, J. Stȩpińska, P. Trindade, A. Voors, F. Zannad, A. Zeiher, J. Bax, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, Ž. Reiner, U. Sechtem, P. Sirnes, M. Tendera, A. Torbicki, A. Vahanian, S. Windecker, L. Bonet, P. Avraamides, Hisham Lamin, M. Brignole, A. Coca, P. Cowburn, H. Dargie, P. Elliott, F. Flachskampf, Guido Guida, S. Hardman, B. Iung, B. Merkely, C. Mueller, J. Nanas, O. Nielsen, S. Ørn, J. Parissis, P. Ponikowski (2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012European Journal of Heart Failure, 14
K. Rabe, S. Hurd, A. Anzueto, P. Barnes, Sonia Buist, P. Calverley, Yoshinosuke Fukuchi, C. Jenkins, R. Rodríguez-Roisín, C. Weel, Jan Zieliński (2007)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.American journal of respiratory and critical care medicine, 176 6
T. Chao, Chia-Jen Liu, Ta-Chuan Tuan, Su-Jung Chen, Kang-Ling Wang, Yenn-Jiang Lin, S. Chang, L. Lo, Yu-Feng Hu, Tzeng-Ji Chen, C. Chiang, Shih‐Ann Chen (2015)
Rate-Control Treatment and Mortality in Atrial FibrillationCirculation, 132
P. Trzepacz, I. Klein, Michelle Roberts, J. Greenhouse, G. Levey (1989)
Graves' disease: an analysis of thyroid hormone levels and hyperthyroid signs and symptoms.The American journal of medicine, 87 5
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.Circulation, 128 16
M. Magnoni, A. Esposito, S. Coli, L. Scuteri, F. Cobelli, D. Cianflone, A. Maschio, A. Maseri (2010)
IMAGE CARDIO MED: Two different mechanisms of myocardial ischemia involving 2 separate myocardial segments in a patient with normal coronary angiography.Circulation, 121 1
Volker Kühlkamp, Alexander Schirdewan, Karl Stangl, Michael Homberg, Matthias Ploch, Otto Beck (2000)
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study.Journal of the American College of Cardiology, 36 1
L. Ven, A. Vermeulen, J.G.M. Tans, A. Tans, K. Liem, N. Lageweg, K. Lie (1995)
Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.International journal of cardiology, 47 3
Michael Jonas, H. Reicher-Reiss, V. Boyko, A. Shotan, L. Mandelzweig, U. Goldbourt, S. Behar (1996)
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group.The American journal of cardiology, 77 15
P. Grant, F. Cosentino (2019)
The 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.European heart journal, 40 39
D. Ladage, C. Reidenbach, Eva Rieckeheer, C. Graf, R. Schwinger, K. Brixius (2010)
Nebivolol Lowers Blood Pressure and Increases Weight Loss in Patients With Hypertension and Diabetes in Regard to AgeJournal of Cardiovascular Pharmacology, 56
T. Ormiston, S. Salpeter (2003)
Beta-blocker use in patients with congestive heart failure and concomitant obstructive airway disease: moving from myth to evidence-based practice.Heart failure monitor, 4 2
U. Sechtem, A. Budaj, J. Ferreira, B. Gersh (2013)
ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
G. Ambrosio, M. Flather, M. Böhm, A. Cohen-Solal, A. Murrone, Flavio Mascagni, G. Spinucci, M. Conti, D. Veldhuisen, L. Tavazzi, A. Coats (2010)
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failureHeart, 97
Kyle Arsenault, A. Yusuf, E. Crystal, J. Healey, C. Morillo, G. Nair, R. Whitlock (2013)
Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery.The Cochrane database of systematic reviews, 1
B. Schoonderwoerd, M. Smit, Lucas Pen, I. Gelder (2008)
New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 10 6
Kazuhiro Yamamoto, H. Origasa, M. Hori (2013)
Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J‐DHF)European Journal of Heart Failure, 15
S. Bangalore, Deepak Bhatt, P. Steg, Michael Weber, W. Boden, C. Hamm, G. Montalescot, A. Hsu, K. Fox, A. Lincoff (2014)
&bgr;-Blockers and Cardiovascular Events in Patients With and Without Myocardial Infarction: Post Hoc Analysis From the CHARISMA TrialCirculation: Cardiovascular Quality and Outcomes, 7
K. Fox, D. Mulcahy, I. Findlay, I. Ford, H. Dargie (1996)
The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.European heart journal, 17 1
M. Gürdoğan, H. Ari, E. Tenekecioğlu, Selma Ari, T. Bozat, V. Koca, M. Melek (2016)
Predictors of Atrial Fibrillation Recurrence in Hyperthyroid and Euthyroid PatientsArquivos Brasileiros de Cardiologia, 106
D. Burgess, M. Kilborn, A. Keech (2006)
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis.European heart journal, 27 23
Joseph Torre, Z. Bloomgarden, R. Dickey, M. Hogan, J. Janick, Sathya Jyothinagaram, H. Siragy (2006)
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 12 2
M. Packer, M. Fowler, E. Roecker, A. Coats, H. Katus, H. Krum, P. Mohacsi, J. Rouleau, M. Tendera, C. Staiger, T. Holcslaw, I. Amann-Zalán, D. DeMets (2002)
Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) StudyCirculation: Journal of the American Heart Association, 106
R. Turner, M. Pirmohamed, M. Pirmohamed (2014)
Cardiovascular Pharmacogenomics: Expectations and Practical BenefitsClinical Pharmacology & Therapeutics, 95
Chirag Bavishi, S. Chatterjee, Sameer Ather, Dipen Patel, F. Messerli (2015)
Beta-blockers in heart failure with preserved ejection fraction: a meta-analysisHeart Failure Reviews, 20
M. Stearne, S. Palmer, M. Hammersley, S. Franklin, R. Spivey, J. Levy, C. Tidy, N. Bell, J. Steemson, B. Barrow, R. Coster, K. Waring, L. Nolan, E. Truscott, N. Walravens, B. Cook, H. Lampard, C. Merle, P. Parker, J. Mcvittie, I. Draisey, L. Murchison, A. Brunt, M. Williams, D. Pearson, X. Petrie, M. Lean, D. Walmsley, F. Lyall, E. Christie, J. Church, E. Thomson, A. Farrow, J. Stowers, M. Stowers, K. McHardy, N. Patterson, A. Wright, N. Levi, A. Shearer, R. Thompson, G. Taylor, S. Rayton, M. Bradbury, A. Glover, A. Smyth-Osbourne, C. Parkes, J. Graham, P. England, S. Gyde, C. Eagle, B. Chakrabarti, J. Smith, J. Sherwell, E. Kohner, A. Dornhorst, M. Doddridge, M. Dumskyj, S. Walji, P. Sharp, M. Sleightholm, G. Vanterpool, C. Rose, G. Frost, M. Roseblade, S. Elliott, S. Forrester, M. Foster, K. Myers, R. Chapman, J. Hayes, T. Henry, M. Featherston, G. Archbold, M. Copeland, R. Harper, I. Richardson, S. Martín, H. Davison, D. Hadden, L. Kennedy, A. Atkinson, A. Culbert, C. Hegan, H. Tennet, N. Webb, I. Robinson, J. Holmes, P. Bell, D. McCance, J. Rutherford, S. Nesbitt, A. Spathis, S. Hyer, M. Nanson, J. James, J. Tyrell, C. Davis, P. Strugnell, M. Booth, H. Petrie, D. Clark, B. Rice, S. Hulland, J. Barron, J. Yudkin, B. Gould, J. Singer, A. Badenock, M. Eckert, K. Alibhai, E. Marriot, C. Cox, R. Price, M. Fernandez, A. Ryle, S. Clarke, G. Wallace, E. Mehmed, S. Macfarlane, R. Greenwood, J. Wilson, M. Denholm, R. Temple, K. Whitfield, F. Johnson, C. Munroe, S. Gorick, E. Duckworth, M. Flatman, S. Rainbow, L. Borthwick, D. Wheatcroft, R. Seaman, R. Christie, W. Wheatcroft, P. Musk, J. White, S. McDougal, M. Bond, P. Raniga, R. Newton, R. Jung, C. Roxburgh, B. Kilgallon, L. Dick, N. Waugh, S. Kilby, A. Ellingford, J. Burns, C. Fox, M. Holloway, H. Coghill, N. Hein, A. Fox, W. Cowan, M. Richard, K. Quested, S. Evans, R. Paisey, N. Brown, A. Tucker, R. Paisey, F. Garrett, J. Hogg, P. Park, K. Williams, Philip Harvey, R. Wilcocks, S. Mason, J. Frost, C. Warren, P. Rocket, L. Bower, J. Roland, D. Brown, J. Youens, K. Stanton-King, H. Mungall, W. Maddison, D. Donnelly, S. King, P. Griffin, S. Smith, S. Church, G. Dunn, Andrew Wilson, K. Palmer, P. Brown, D. Humphriss, A. Davidson, R. Rose, L. Armistead, S. Townsend, P. Poon, I. Peacock, N. Culverwell, M. Charlton, B. Connolly, J. Peacock, J. Barrett, J. Wain, W. Beeston, G. King, P. Hill, A. Boulton, A. Robertson, Katoulis, A. Olukoga, H. McDonald, S. Kumar, F. Abouaesha, B. Abuaisha, E. Knowles, S. Higgins, J. Booker, J. Sunter, K. Breislin, R. Parker, P. Raval, J. Curwell, H. Davenport, G. Shawcross, A. Prest, J. Grey, H. Cole, C. Sereviratne, R. Young, T. Dornan, J. Clyne, M. Gibson, I. O'Connell, L. Wong, S. Wilson, K. Wright, C. Wallace, D. McDowell, A. Burden, E. Sellén, R. Gregory, M. Roshan, N. Vaghela, M. Burden, C. Sherriff, J. Clarke, J. Grenfell, J. Tooke, K. Macleod, C. Searnark, M. Rammell, C. Pym, J. Stockman, C. Yeo, J. Piper, L. Leighton, E. Green, M. Hoyle, K. Jones, A. Hudson, A. James, A. Shore, A. Higham, B. Martin (1998)
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 317
B. Olshansky, L. Rosenfeld, A. Warner, A. Solomon, G. O’Neill, Arjun Sharma, E. Platia, G. Feld, T. Akiyama, M. Brodsky, H. Greene, Affirm Investigators (2004)
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.Journal of the American College of Cardiology, 43 7
B. Lipworth, D. Skinner, G. Devereux, V. Thomas, Joanna Jie, Jessica Martin, V. Carter, D. Price (2016)
Underuse of β-blockers in heart failure and chronic obstructive pulmonary diseaseHeart, 102
R. Turner, R. Holman (1998)
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.BMJ
H. Dargie (2001)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trialThe Lancet, 357
M. Bristow, E. Gilbert, W. Abraham, K. Adams, M. Fowler, R. Hershberger, S. Kubo, K. Narahara, H. Ingersoll, S. Krueger, S. Young, N. Shusterman (1996)
Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.Circulation, 94 11
R. Doughty, A. Rodgers, N. Sharpe, S. MacMahon (1997)
Effects of beta-blocker therapy on mortality in patients with heart failure. A systematic overview of randomized controlled trials.European heart journal, 18 4
(1981)
Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction.The New England journal of medicine, 304 14
(2003)
HLA-MATCHING AND PRETRANSPLANT BLOOD TRANSFUSIONS IN CADAVERIC RENAL TRANSPLANTATION—A CHANGING PICTURE WITH CYCLOSPORIN
(2013)
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD)Eur Heart J, 34
(2011)
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)Eur Heart J, 32
M. Landray, V. Toescu, M. Kendall (2002)
The cardioprotective role of β‐blockers in patients with diabetes mellitusJournal of Clinical Pharmacy and Therapeutics, 27
H. Blessberger, J. Kammler, H. Domanovits, O. Schlager, B. Wildner, Danyel Azar, M. Schillinger, F. Wiesbauer, C. Steinwender (2018)
Perioperative beta-blockers for preventing surgery-related mortality and morbidity.The Cochrane database of systematic reviews, 3
J. Kjekshus, E. Gilpin, Geraldine Cali, A. Blackey, H. Henningj, J. Ross (1990)
Diabetic patients and beta-blockers after acute myocardial infarction.European heart journal, 11 1
P. Shekelle, M. Rich, S. Morton, Col Atkinson, W. Tu, M. Maglione, S. Rhodes, M. Barrett, G. Fonarow, B. Greenberg, P. Heidenreich, Tom Knabel, M. Konstam, A. Steimle, Lynne Stevenson (2003)
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials.Journal of the American College of Cardiology, 41 9
G. Marazzi, M. Volterrani, G. Caminiti, L. Iaia, R. Massaro, C. Vitale, B. Sposato, G. Mercuro, G. Rosano (2011)
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients.Journal of cardiac failure, 17 9
S. Salpeter, T. Ormiston, E. Salpeter, P. Poole, C. Cates (2005)
Cardioselective beta-blockers for chronic obstructive pulmonary disease.The Cochrane database of systematic reviews, 2
S. Nodari, M. Metra, L. Cas (2003)
β‐Blocker treatment of patients with diastolic heart failure and arterial hypertension. A prospective, randomized, comparison of the long‐term effects of atenolol vs. nebivololEuropean Journal of Heart Failure, 5
R. Shorr, W. Ray, J. Daugherty, M. Griffin (1997)
Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas.JAMA, 278 1
M. Packer, A. Coats, M. Fowler, H. Katus, H. Krum, P. Mohacsi, J. Rouleau, M. Tendera, A. Castaigne, E. Roecker, M. Schultz, D. DeMets (2001)
Effect of carvedilol on survival in severe chronic heart failure.The New England journal of medicine, 344 22
P. Heidenreich, P. Heidenreich, Tina Lee, B. Massie (1997)
Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials.Journal of the American College of Cardiology, 30 1
S. Bangalore, S. Parkar, E. Grossman, F. Messerli (2007)
A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus.The American journal of cardiology, 100 8
Imad Nasr, A. Bouzamondo, J. Hulot, O. Dubourg, J. Heuzey, P. Lechat (2007)
Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.European heart journal, 28 4
Å. Hjalmarson, S. Goldstein, B. Fagerberg, H. Wedel, F. Waagstein, J. Kjekshus, J. Wikstrand, D. Allaf, J. Vítovec, J. Aldershvile, M. Halinen, R. Dietz, K. Neuhaus, A. Jánosi, G. Thorgeirsson, P. Dunselman, L. Gullestad, J. Kuch, J. Herlitz, P. Rickenbacher, S. Ball, S. Gottlieb, P. Deedwania (2000)
Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)Survey of Anesthesiology, 44
M. Flather, M. Shibata, A. Coats, D. Veldhuisen, A. Parkhomenko, Joszef Borbola, A. Cohen-Solal, D. Dumitrascu, R. Ferrari, P. Lechat, J. Soler‐Soler, L. Tavazzi, L. Špinarová, J. Toman, M. Böhm, S. Anker, S. Thompson, P. Poole‐Wilson (2005)
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).European heart journal, 26 3
M. Gheorghiade, W. Colucci, K. Swedberg (2003)
Blockers in Chronic Heart Failure
(2000)
Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study GroupJAMA, 283
R. Wali, M. Iyengar, G. Beck, D. Chartyan, M. Chonchol, M. Lukas, C. Cooper, J. Himmelfarb, M. Weir, T. Berl, W. Henrich, A. Cheung (2011)
Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease: A Meta-Analysis of Randomized TrialsCirculation: Heart Failure, 4
M. Hori, S. Sasayama, A. Kitabatake, T. Toyo-Oka, S. Handa, M. Yokoyama, M. Matsuzaki, A. Takeshita, H. Origasa, K. Matsui, S. Hosoda (2004)
Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.American heart journal, 147 2
L. Dominguez, Mario Barbagallo, Scott Jacober, David Jacobs, James Sowers (1997)
Bisoprolol and captopril effects on insulin receptor tyrosine kinase activity in essential hypertension.American journal of hypertension, 10 12 Pt 1
M. Domanski, H. Krause-Steinrauf, P. Deedwania, D. Follmann, J. Ghali, E. Gilbert, S. Haffner, R. Katz, J. Lindenfeld, B. Lowes, W. Martin, F. Mcgrew, M. Bristow (2003)
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.Journal of the American College of Cardiology, 42 5
J. Buse, D. Wexler, A. Tsapas, P. Rossing, G. Mingrone, C. Mathieu, D. D’Alessio, M. Davies (2019)
2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 63
(1995)
Diabetes in America. DIANE Publishing, 2 edition. NIH Publication No. 95-1468
(2012)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEur Heart J, 33
Bing Wang, Wei-hua Song, Guo-zhang Liu (2005)
[The effect long-term administration of a selective beta1 blocker bisoprolol on glucose metabolism in patients with essential hypertensive and type 2 diabetes mellitus].Zhonghua nei ke za zhi, 44 7
(Cadrin-Tourigny J, Shohoudi A, Roy D, et al. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy. JACC Heart Fail. 2017.)
Cadrin-Tourigny J, Shohoudi A, Roy D, et al. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy. JACC Heart Fail. 2017.Cadrin-Tourigny J, Shohoudi A, Roy D, et al. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy. JACC Heart Fail. 2017., Cadrin-Tourigny J, Shohoudi A, Roy D, et al. Decreased mortality with beta-blockers in patients with heart failure and coexisting atrial fibrillation: an AF-CHF substudy. JACC Heart Fail. 2017.
Leo Putte, M. Nichol (2012)
Adalimumab for Rheumatoid ArthritisDisease Management & Health Outcomes, 12
(1995)
NIH Publication No. 95-1468. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of essential hypertension. However, they remain the drugs of first choice in recommendations from the respective medical societies for heart failure, coronary artery disease, and atrial fibrillation as well as in hypertension complicated with heart failure, angina pectoris, or prior myocardial infarction. When indicated, cardioselective β-blockers should be prescribed in patients with diabetes mellitus or chronic obstructive pulmonary disease. We review the available evidence for the use of β-blockers in clinical conditions in which recommendations can be made for everyday practice.
American Journal of Cardiovascular Drugs – Springer Journals
Published: Mar 29, 2017
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.